Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Evaluation of the Pharmacokinetics of Sublingual IPX237 in Healthy Volunteers

To see complete record on, please visit this link

Id: ACTRN12614000444684

Organisation Name: Impax Pharmaceuticals,A Division of Impax Laboratories, Inc.

Overal Status: Completed

Start Date: 01/07/2014

Brief Summary: To characterize the pharmacokinetics (PK), safety, and tolerability of sublingually administered esketamine hydrochloride from IPX237 at two dose strengths, and to evaluate the effect of formulation retention in the sublingual space.

  • Australia
  • United States of America

Total execution time in seconds: 0.1513409614563